What is going to happen to the E.U.? Leslie Kossoff joins Jim Blasingame from Paris to talk about the challenges before the European Union and the likelihood that it will not stay intact as it is currently structured.

Who is the Obama campaign the most frightened of? Former Congressman Bob Beauprez joins Jim Blasingame to reveal which Republican candidate is the most likely to beat Obama.

Main Street Americans have to take back our country. Former Congressman, Bob Beauprez, joins Jim Blasingame to talk about Main Street values and why they must become more a part of the debate about the future of America.

The 21st century is The Century of the Entrepreneur. Gene Marks joins Jim Blasingame to discuss the global growth in entrepreneurship and why that will ultimately produce a peace dividend.

How do you get people to want what you want? Rick Maurer joins Jim Blasingame to discuss the Influence, Action, Change approach to leading change in any organization.

Do you have someone to help you edit your story? Stephen Baum joins Jim Blasingame to talk about the process of getting your story right by telling it to others before you take it to the marketplace.

Is the story you're telling yourself holding you back? Stephen Baum joins Jim Blasingame to explain how to determine if the story you're telling is a productive one or if it's contributing to problems in your life.

When a senior business owner tells their story - listen. Stephen Baum joins Jim Blasingame to talk about the lessons that can be learned from Jack Nadal's story, and why storytelling is powerful.

What strategy should the Republican candidates use to defeat President Obama? Douglas Holtz-Eakin joins Jim Blasingame to reveal that attacking Obama the person won't work as a political strategy, the focus must be on his policies.

Why does the future of American health care innovation look so bleak? Douglas Holtz-Eakin joins Jim Blasingame to reveal the numerous political and policy impediments to health care innovation in the U.S., including tax policy, the FDA and ObamaCare.